Moderna and Johnson & Johnson are also researching their vaccine in teenagers and younger children.
Vaccination of the German biotechnology company CureVac against coronavirus disease (COVID-19) will be given to a volunteer at the start of a series of clinical trials at the University of Tuebingen, Germany. Reuters
The United States is expected to authorize Pfizer-BioNTech COVID-19 vaccine for children 12 and older by the beginning of next week, U.S. media reported Monday. Pfizer has applied for its Covid vaccine for emergency use in children and adolescents aged 12-15 years. CNN, citing a government official. “The FDA needs to change the vaccine’s emergency authorization, but the process should be simple” CNN reported.
The U.S. Food and Drug Administration is expected to grant approval by early next week. Following the FDA’s decision, the Advisory Board of Centers for Disease Control and Prevention will meet to recommend the use of the vaccine.
An FDA spokesman declined to provide more detailed information on the approval schedule Washington Post: “We are working to review this request as quickly and transparently as possible.”
The Pfizer vaccine is currently approved for people 16 years of age and older in the United States.
The U.S. drug giant reported in late March that it had submitted data from 2,260 clinical trials of 12 to 15 years of age that showed the vaccine to be highly effective and well tolerated. Testing of younger children continues.
Moderna is conducting vaccine trials in teens, and results are expected in the summer as well as in younger children.
Johnson & Johnson is also planning child trials for its vaccine.
Extending the vaccination license to young people could open up the U.S. mass vaccination program to millions of people.
National vaccination rates peaked on April 11, according to official data, and although 55 percent of U.S. adults have now had one or more doses, there is still a long way to go against Covid.
People who are most eager to take their shots have, for the most part, already rolled up their sleeves and done so.
But hesitation about vaccines remains a major hurdle: A large percentage of U.S. adults do not plan to shoot shots and may potentially refuse to vaccinate their children.
According to a recent study by the Kaiser Family Foundation, 29 percent of Republican voters say they never take the vaccine, while five percent are Democrats and nine percent are independent.